Responses
Therapeutics
Women's Health Initiative randomised ontrolled trial
Combined estrogen plus progestin may reduce coronary heart disease risk after 5 years of use in postmenopausal women starting treatment within 10 years of menopause
Compose a Response to This Article
Other responses
No responses have been published for this article.